KLP Kapitalforvaltning’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Hold
6,600
﹤0.01% 1869
2026
Q1
$233K Hold
6,600
﹤0.01% 1765
2025
Q4
$268K Buy
6,600
+300
+5% +$13.1K ﹤0.01% 1727
2025
Q3
$297K Hold
6,300
﹤0.01% 1658
2025
Q2
$329K Hold
6,300
﹤0.01% 1561
2025
Q1
$382K Hold
6,300
﹤0.01% 1446
2024
Q4
$432K Buy
+6,300
New +$439K ﹤0.01% 1460

Other funds holding CNMD

KLP Kapitalforvaltning's CNMD Position: Q2 2026 in Review

KLP Kapitalforvaltning held its CONMED (CNMD) position steady in Q2 2026 at 6,600 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1869.

KLP Kapitalforvaltning first reported a position in CNMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $432K in Q4 2024. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • KLP Kapitalforvaltning held 6,600 shares of CONMED worth $216K as of Q2 2026.
  • KLP Kapitalforvaltning left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1869 holding.
  • KLP Kapitalforvaltning first reported a position in CONMED in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's CONMED position peaked at $432K in Q4 2024.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.